16-1209370-C-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_021098.3(CACNA1H):c.3702C>T(p.Ser1234Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000277 in 1,445,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000028 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.644
Publications
1 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 16-1209370-C-T is Benign according to our data. Variant chr16-1209370-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 1583944.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.3663C>T | p.Ser1221Ser | synonymous_variant | Exon 17 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.3663C>T | p.Ser1221Ser | synonymous_variant | Exon 17 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.3702C>T | p.Ser1234Ser | synonymous_variant | Exon 17 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*1615C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*3149C>T | non_coding_transcript_exon_variant | Exon 16 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.3702C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*1615C>T | 3_prime_UTR_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*3149C>T | 3_prime_UTR_variant | Exon 16 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD2 exomes AF: 0.0000130 AC: 3AN: 230912 AF XY: 0.0000235 show subpopulations
GnomAD2 exomes
AF:
AC:
3
AN:
230912
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000277 AC: 4AN: 1445632Hom.: 0 Cov.: 32 AF XY: 0.00000556 AC XY: 4AN XY: 719542 show subpopulations
GnomAD4 exome
AF:
AC:
4
AN:
1445632
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
719542
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33452
American (AMR)
AF:
AC:
3
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26100
East Asian (EAS)
AF:
AC:
0
AN:
39684
South Asian (SAS)
AF:
AC:
1
AN:
86244
European-Finnish (FIN)
AF:
AC:
0
AN:
37922
Middle Eastern (MID)
AF:
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1111528
Other (OTH)
AF:
AC:
0
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 04, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.